Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Indian J Ophthalmol ; 72(3): 427-431, 2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-38146971

RESUMO

PURPOSE: To study and compare the efficacy and safety profile of Rho-kinase inhibitor (netarsudil 0.02%) and prostaglandin analog (bimatoprost 0.01%) both as monotherapy and in combination. DESIGN: Prospective, randomized, monocentric, open-label clinical trial. METHODS: Patients ≥20 years of age with primary open-angle glaucoma or ocular hypertension (IOP >21 mmHg) were recruited and randomized to receive either netarsudil 0.02%, netarsudil 0.02% + bimatoprost 0.01%, or bimatoprost 0.01% once daily for a period of 12 weeks. IOP and side effects were documented at 4, 8, and 12 weeks. RESULTS: The mean treated IOP ranged 17.51-18.57 mmHg for netarsudil, 15.80-16.46 mmHg for bimatoprost, and 14.00-14.87 mmHg for the combination therapy group. The mean IOP reduction from baseline at 4, 8, and 12 weeks was found to be statistically significant ( P < 0.001) in all three groups. The safety profile of netarsudil/bimatoprost combination was consistent with each constituent individually. The only frequently observed ocular adverse event was conjunctival hyperemia, which was seen mostly in netarsudil and netarsudil + bimatoprost groups ( P < 0.001). CONCLUSION: The IOP-lowering effect of netarsudil 0.02% once daily is non-inferior to bimatoprost 0.01% in patients with POAG and ocular hypertension with acceptable ocular safety, and the combination therapy achieved a higher IOP-lowering effect. This group of medications can be a useful adjunct in patients on maximal therapy.


Assuntos
Benzoatos , Glaucoma de Ângulo Aberto , Glaucoma , Hipertensão Ocular , beta-Alanina/análogos & derivados , Humanos , Lactente , Bimatoprost/uso terapêutico , Glaucoma de Ângulo Aberto/tratamento farmacológico , Estudos Prospectivos , Pressão Intraocular , Anti-Hipertensivos/uso terapêutico , Hipertensão Ocular/tratamento farmacológico , Glaucoma/tratamento farmacológico , Resultado do Tratamento , Soluções Oftálmicas
2.
Middle East Afr J Ophthalmol ; 22(1): 122-4, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25624688

RESUMO

Oculocerebrocutaneous or Delleman syndrome is a rare congenital syndrome characterized by microphthalmia/anophthalmia with or without orbital cysts, focal skin defects, intracranial cysts and skin appendages. We here report a case of 1-year-old male child with periocular skin tags, lid colobomas, and dermal hypoplasia. The patient had delayed developmental milestones and history of tonic-clonic seizures. Magnetic resonance imaging of the head revealed a large arachnoid cyst, aplastic cerebellar vermis and polymicrographic pattern of the cerebral cortex. A complex cyst of spleen was also noted on abdominal ultrasonography. Orbital cysts depending on the size can be excised or left alone. Neuroimaging evaluation of patients with congenital orbital cysts and skin appendages is emphasized for early and appropriate management.


Assuntos
Cistos do Sistema Nervoso Central/complicações , Anormalidades do Olho/complicações , Dedos/anormalidades , Anormalidades da Pele/complicações , Cistos Aracnóideos/diagnóstico , Cistos do Sistema Nervoso Central/patologia , Coloboma/diagnóstico , Cistos/diagnóstico , Anormalidades do Olho/patologia , Pálpebras/anormalidades , Dedos/patologia , Humanos , Lactente , Imageamento por Ressonância Magnética , Masculino , Doenças Orbitárias/diagnóstico , Anormalidades da Pele/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...